NewsBenzingaUBS maintient un avis d'achat sur Westlake, mais abaisse l'objectif de cours à 98 $ UBS maintient un avis d'achat sur Westlake, mais abaisse l'objectif de cours à 98 $ Benzinga 2026.09.25 16:16 (GMT+0) Open on Benzinga Other news What's Going On With Kinros Gold Stock Today? 'JPMorgan Tweaks Data-Sharing Notices in Battle With Fintechs' - Bloomberg Fresenius Medical Care Refines China Strategy With Targeted Product Focus Stock of the Day: Is this the Bottom for MGM Resorts? Why Is GameStop Stock Falling on Friday? Moleculin Biotech Announces Preclinical Data Showing Annamycin Antitumor Activity In Pancreatic Cancer Is Immune-Mediated
Moleculin Biotech Announces Preclinical Data Showing Annamycin Antitumor Activity In Pancreatic Cancer Is Immune-Mediated
